Results 121 to 130 of about 2,457 (145)

Harnessing outer membrane vesicles derived from <i>Bordetella pertussis</i> to overcome key limitations of acellular pertussis vaccines. [PDF]

Front Immunol
Locati L, Bottero D, Carriquiriborde F, López O, Pschunder B, Zurita E, Martin Aispuro P, Gaillard ME, Hozbor D.   +8 more
europepmc   +1 more source

The Battle Against Pertussis: Discovery of Endogenous Human Proteins and Peptides as Toxin-Inhibitors. [PDF]

Toxins (Basel)
Lietz S, Barth H.
europepmc   +1 more source

Pertussis Vaccination for Adults: An Updated Guide for Clinicians. [PDF]

Vaccines (Basel)
See KC.
europepmc   +1 more source

Molecular epidemiology and increasing macrolide resistance of Bordetella pertussis isolates in Guangzhou, China. [PDF]

BMC Infect Dis
Mai Q, Wen J, Luo Y, Guo J, Qin Y, Lai W, Deng W, Ji C, Mai R, Zheng M, Chen Z, Chen Y, Gu C, Guo L, Li H, Tang Y, Huang D, Luo M.   +17 more
europepmc   +1 more source

Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China. [PDF]

Emerg Microbes Infect
Zhang W, Wei C, Wan P, Feng G, Wang F, Wang L, Tan J, Wang X, Wang X, Sui X, You W, Gou J, Yuan L, Zhu T, Huang H, Ma X, Wang Y.   +16 more
europepmc   +1 more source

Antibody in Breastmilk Following Pertussis Vaccination in Three-time Windows in Pregnancy. [PDF]

Pediatr Infect Dis J
Daniel O, Loughnan M, Quenby M, Chawla K, Greening V, T Heath P, Jones CE, Khalil A, Ramkhelawon L, Calvert A, Le Doare K, MAMA/OpTIMUM breastmilk study group.   +11 more
europepmc   +1 more source

<i>GWarrange</i>: a pre- and post- genome-wide association studies pipeline for detecting phenotype-associated genome rearrangement events. [PDF]

Microb Genom
Tam YL, Cameron S, Preston A, Cowley L.
europepmc   +1 more source

Pertussis-A Re-Emerging Threat Despite Immunization: An Analysis of Vaccine Effectiveness and Antibiotic Resistance. [PDF]

Int J Mol Sci
Duda-Madej A, Łabaz J, Topola E, Bazan H, Viscardi S.   +4 more
europepmc   +1 more source

Recombinant P.69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection

Vaccine, 1992
The immunogenicity of recombinant (r-) pertactin was examined. Parenteral immunization of mice with natural or r-pertactin produced a similar increase in serum anti-pertactin antibodies and a decrease in Bordetella pertussis lung counts following aerosol
I G Charles, J P Tite
exaly   +2 more sources

Bordetella parapertussis isolates not expressing pertactin circulating in France [PDF]

Clinical Microbiology and Infection, 2011
Surprisingly, most Bordetella parapertussis isolates collected in France since 2007 do not express pertactin, owing to mutations in the structural gene encoding this protein.
N Guiso
exaly   +2 more sources